Hematolgy Oncology Solutions is categorized under in Tallahassee, FL and active since 2012.
Hematolgy Oncology Solutions was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Marie Amanze, Owner at the company’s single location by writing to 2617 Mitcham Drive # 101, Tallahassee, Florida FL 32308 or by phoning (850) 727-8540. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hematolgy Oncology Solutions |
| Contact Person: | Marie Amanze, Owner |
| Address: | 2617 Mitcham Drive # 101, Tallahassee, Florida 32308 |
| Phone Number: | (850) 727-8540 |
| Website Address: | hemoncsolutions.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 8069 |
| NAICS Code: | 6211110 |
| Share This Business: |
Hematolgy Oncology Solutions was started in 2012 to provide professional under the SIC code 8069 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Marie Amanze, Owner for inquiries that concern Hematolgy Oncology Solutions by calling the company number (850) 727-8540, as your correspondence is most welcome. Additionally, the physical location of the single location of Hematolgy Oncology Solutions can be found at the coordinates 30.45823,-84.23688 as well as the street address 2617 Mitcham Drive # 101 in Tallahassee, Florida 32308.
For its online presence, you may visit Hematolgy Oncology Solutions’s website at hemoncsolutions.com and engage with its social media outlets through on Twitter and on Facebook.